...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Zenith BIO CEO & Investor Conference 2017 Slides
Reply New Message
Back To Forum List View
Icon president Zenith BIO CEO & Investor Conference 2017 Slides
3
BearDownAZ
Feb 14, 2017 12:17PM
Re: Zenith BIO CEO & Investor Conference 2017 Slides
3
fouremm
Feb 14, 2017 04:36PM
Icon president Re: Zenith BIO CEO & Investor Conference 2017 Slides
2
BearDownAZ
Feb 14, 2017 06:39PM
Icon president Re: Zenith BIO CEO & Investor Conference 2017 Slides
2
SanFrancisco99
Feb 14, 2017 09:56PM

SF

 

Option 4     Pending  M & A/partnership/license deal/CVR  possibility ???,  which will be released in a PR and I quote "when they are duly executed"   paraphase  LOL

This  might just explain that cancellation of teh AGM back in September but maybe your right Option 1 and 2 could be a possibility as well.....

3 Recommendations
Re: Zenith BIO CEO & Investor Conference 2017 Slides
1
tada
Feb 15, 2017 10:54AM
Icon president Re: Zenith BIO CEO & Investor Conference 2017 Slides

SanFrancisco99
Feb 15, 2017 02:10PM
Re: Zenith BIO CEO & Investor Conference 2017 Slides
1
tada
Feb 15, 2017 04:54PM
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply